Search clinical trials for: Diamel

Total 8 results

Catalysis SL

Completed

Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema

Diabetic Macular Edema

Cuba
Pfizer

Terminated

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects (SPIRE-2)

Cardiovascular Disease

United States, Finland, Netherlands, Spain, Belgium, Germany, Czechia, Switzerland, Denmark, Australia, United Kingdom, Korea, Republic of, Hungary, Israel, Poland, Taiwan, Mexico, Turkey, Ireland, Canada, New Zealand, South Africa, Brazi... and more
Catalysis SL

Completed

Evaluation of DIAMEL® Combined With Insulin in Diabetic Foot Ulcer

Diabetes Mellitus, Type 2 | Diabetic Foot | Diabetic Foot Ulcer

Cuba
Pfizer

Terminated

The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects (SPIRE-1)

Cardiovascular Disease

Finland, United States, Netherlands, Spain, Korea, Republic of, China, Israel, Belgium, Germany, Australia, Czechia, Taiwan, Denmark, United Kingdom, Hungary, Poland, France, Mexico, Turkey, Canada, New Zealand, Colombia, Switzerland, Irelan... and more
Catalysis SL

Completed

Diamel in the Treatment of Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Cuba
Catalysis SL

Completed

Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis

Insulin Resistance | Nonalcoholic Steatohepatitis

Cuba
Catalysis SL

Completed

Diamel in the Treatment of Type 2 Diabetic Patients Receiving Insulin Therapy

Type 2 Diabetes

Cuba
Catalysis SL

Completed

Diamel in the Treatment of Metabolic Syndrome

Metabolic Syndrome

Cuba

Search clinical trials for: Diamel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations